{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:42:36Z","timestamp":1778895756078,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neulet.2022.136657","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T19:51:03Z","timestamp":1650916263000},"page":"136657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chronic oral olanzapine treatment but not haloperidol decreases [3H] MK-801 binding in the rat brain Independent of dietary conditions"],"prefix":"10.1016","volume":"781","author":[{"given":"Leah","family":"Waldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayotis","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-3057(87)90340-6","article-title":"Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?","volume":"27","author":"Baptista","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.neulet.2022.136657_b0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"22","key":"10.1016\/j.neulet.2022.136657_b0015","first-page":"3354","article-title":"Cingulate Cortex in Schizophrenia: its relation with negative symptoms and psychotic onset. A review study","volume":"18","author":"Bersani","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2022.136657_b0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1471-244X-12-221","article-title":"Amphetamine-induced psychosis\u2013a separate diagnostic entity or primary psychosis triggered in the vulnerable?","volume":"12","author":"Bramness","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neulet.2022.136657_b0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.01.004","article-title":"Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory","volume":"59","author":"Camer","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.neulet.2022.136657_b0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archpsyc.62.10.1071","article-title":"Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia","volume":"62","author":"Cannon","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2022.136657_b0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2022.136657_b0045","article-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"1996","journal-title":"The National Academies Press"},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1098-2396(199904)32:1<67::AID-SYN9>3.0.CO;2-Q","article-title":"Decreased hippocampal (CA3) NMDA receptors in schizophrenia","volume":"32","author":"Dean","year":"1999","journal-title":"Synapse"},{"issue":"Pt B","key":"10.1016\/j.neulet.2022.136657_b0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pnpbp.2017.06.005","article-title":"Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet","volume":"79","author":"Delis","year":"2017","journal-title":"Progr. Neuro-psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neulet.2022.136657_b0060","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301002","article-title":"Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique","volume":"31","author":"Fatemi","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neulet.2022.136657_b0065","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/oby.2010.6","article-title":"Increased food intake and energy expenditure following administration of olanzapine to healthy men","volume":"18","author":"Fountaine","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.neulet.2022.136657_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-3223(01)01321-X","article-title":"Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine","volume":"51","author":"Goff","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neulet.2022.136657_b0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2013.04.017","article-title":"Substantia nigra hyperactivity in schizophrenia","volume":"74","author":"Heckers","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S1461145700001978","article-title":"N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade","volume":"3","author":"Heresco-Levy","year":"2000","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nyas.12547","article-title":"The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies","volume":"1338","author":"Hu","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2022.136657_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110159","article-title":"The integrated model of glutamate and dopamine hypothesis for schizophrenia: Prediction and personalized medicine for prevent potential treatment-resistant patients","volume":"143","author":"Huang","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"11","key":"10.1016\/j.neulet.2022.136657_b0095","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1176\/appi.ajp.157.11.1811","article-title":"Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia","volume":"157","author":"Ibrahim","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2022.136657_b0100","doi-asserted-by":"crossref","first-page":"118708","DOI":"10.1016\/j.lfs.2020.118708","article-title":"Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding","volume":"264","author":"Jalloh","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neulet.2022.136657_b0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002130050277","article-title":"The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study","volume":"131","author":"Kapur","year":"1997","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neulet.2022.136657_b0110","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation","volume":"155","author":"Kapur","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.neulet.2022.136657_b0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2012.03.015","article-title":"Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings","volume":"138","author":"Karnik-Henry","year":"2012","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.neulet.2022.136657_b0120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ijnp\/pyx045","article-title":"Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study","volume":"20","author":"Kiparizoska","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.neulet.2022.136657_b0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.pharep.2015.01.017","article-title":"Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus","volume":"67","author":"Krzystanek","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.neulet.2022.136657_b0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/hipo.23295","article-title":"Goal-directed interaction of stimulus and task demand in the parahippocampal region","volume":"31","author":"Lee","year":"2021","journal-title":"Hippocampus"},{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2022.136657_b0140","doi-asserted-by":"crossref","first-page":"135976","DOI":"10.1016\/j.neulet.2021.135976","article-title":"A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain","volume":"757","author":"Maredia","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0145","first-page":"15","article-title":"Dopamine and glutamate in schizophrenia: biology, symptoms and treatment","volume":"19","author":"McCutcheon","year":"2020","journal-title":"World Psychiatry Official J. World Psychiatric Association (WPA)"},{"issue":"7","key":"10.1016\/j.neulet.2022.136657_b0150","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neulet.2022.136657_b0155","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1046\/j.1471-4159.1996.67051965.x","article-title":"Effects of Subchronic Clozapine and Haloperidol on Striatal Glutamatergic Synapses [10.1046\/j.1471-4159.1996.67051965.x]","volume":"67","author":"Meshul","year":"1996","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neulet.2022.136657_b0160","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.neulet.2022.136657_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molbrainres.2003.11.004","article-title":"Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia","volume":"121","author":"Mueller","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pscychresns.2015.11.001","article-title":"Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation","volume":"234","author":"Nelson","year":"2015","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.neulet.2022.136657_b0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/PL00005353","article-title":"Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats","volume":"359","author":"Ossowska","year":"1999","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0180","first-page":"49","article-title":"Influence of long-lasting administration of neuroleptics on cortical NMDA receptors and phencyclidine-induced deficit in the sensorimotor gating in rats","volume":"51","author":"Ossowska","year":"1999","journal-title":"Pol. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neulet.2022.136657_b0185","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1471-4159.1995.64020614.x","article-title":"Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential","volume":"64","author":"Porter","year":"1995","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.neulet.2022.136657_b0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881116667668","article-title":"Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine","volume":"30","author":"Reynolds","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neulet.2022.136657_b0195","doi-asserted-by":"crossref","first-page":"110407","DOI":"10.1016\/j.pnpbp.2021.110407","article-title":"Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellum","volume":"112","author":"Richardson","year":"2022","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/srep46288","article-title":"Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity","volume":"7","author":"Sacchi","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neulet.2022.136657_b0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1022325116309","article-title":"Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits","volume":"28","author":"Schmitt","year":"2003","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/nimg.1998.0387","article-title":"Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with functional magnetic resonance imaging","volume":"9","author":"Schr\u00f6der","year":"1999","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neulet.2022.136657_b0215","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/schbul\/sbj030","article-title":"Hippocampal and parahippocampal volumes in schizophrenia: a structural MRI study","volume":"32","author":"Sim","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.neulet.2022.136657_b0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<266::AID-SYN3>3.0.CO;2-2","article-title":"Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats","volume":"34","author":"Spurney","year":"1999","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2045125314557797","article-title":"Drug models of schizophrenia","volume":"5","author":"Steeds","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0230","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1124\/jpet.103.052597","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment","volume":"306","author":"Tarazi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neulet.2022.136657_b0235","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.neuroscience.2007.03.003","article-title":"Oral haloperidol or risperidone treatment in rats: Temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance","volume":"146","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neulet.2022.136657_b0240","doi-asserted-by":"crossref","first-page":"E396","DOI":"10.1152\/ajpendo.00343.2011","article-title":"High-fat diets induce changes in hippocampal glutamate metabolism and neurotransmission","volume":"302","author":"Valladolid-Acebes","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neulet.2022.136657_b0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2010.05.009","article-title":"Olanzapine affects locomotor activity and meal size in male rats","volume":"97","author":"van der Zwaal","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neulet.2022.136657_b0250","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ijo.2011.97","article-title":"The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature","volume":"36","author":"van der Zwaal","year":"2012","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.neulet.2022.136657_b0255","unstructured":"Watson, P. (2014). Paxinos and Watson's The Rat Brain in Stereotaxic Coordinates, 7th Edition. In (Vol. 1). Beaverton: Ringgold Inc."},{"issue":"6","key":"10.1016\/j.neulet.2022.136657_b0260","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.neulet.2022.136657_b0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.schres.2010.08.027","article-title":"The role of the insula in schizophrenia","volume":"123","author":"Wylie","year":"2010","journal-title":"Schizophr. Res."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394022002142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394022002142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:43:28Z","timestamp":1759625008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394022002142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":53,"alternative-id":["S0304394022002142"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2022.136657","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic oral olanzapine treatment but not haloperidol decreases [3H] MK-801 binding in the rat brain Independent of dietary conditions","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2022.136657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"136657"}}